QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) Vaccine
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Capecitabine
Related studies linked through entity extraction aliases.
QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
QUILT-3.088: NANT Pancreatic Cancer Vaccine
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of the Addition of Metronomic Capecitabine to Standard Adjuvant Therapy in High Risk HER2+ BC paTients
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02]
- Status
- COMPLETED
- Phase
- PHASE3
Use of High-dose Radiation Therapy Plus Chemotherapy to Improve the Likelihood of Surgical Treatment in Patients With Locally Advanced Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Molecular Profile of Breast Cancer in Ugandan Patients With Stage IIB-III Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Postoperative Chemoradiation or Chemotherapy After Preoperative Chemotherapy for Gastric Cancers
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD
- Status
- TERMINATED
- Phase
- PHASE2
A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
OXEL: Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for TNBC With Residual Disease
- Status
- COMPLETED
- Phase
- PHASE2
A Pilot Study of the Combination of Entinostat With Capecitabine in High Risk Breast Cancer After Neo-adjuvant Therapy
- Status
- COMPLETED
- Phase
- PHASE1
A Study of SHR-1210 in Combination With Capecitabine + Oxaliplatin or Apatinib in Treatment of Advanced Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
BGB A317 in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Association of Capecitabine Pharmacokinetics and Toxicity With Aging
- Status
- UNKNOWN
- Phase
- PHASE4
First-line Combination of Capecitabine and Oxaliplatin Plus Bevacizumab in Elderly Patients With Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Bioequivalence Study of Capecitabine Tablets 500 mg in Adult Cancer Patients Under Fed Condition
- Status
- UNKNOWN
- Phase
- PHASE1
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2